ResearcherPasteur Institute of IranNo recent work listed
Ladan Teimoori-Toolabi
Matched on ORCID iD 0000-0002-6588-9774; OpenAlex author ID A5055158419.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 0, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 4
2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers
Papers 3
- MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic … Last author DOI 10.1007/s00280-017-3418-2↗
- Molecular alterations contributing to pancreatic cancer chemoresistance. Last author DOI 10.1016/j.pan.2016.12.013↗
- MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. Co-author DOI 10.4161/cbt.27630↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Azam Rajabpour · 2 shared papers, 2017
- Ali Afgar · 1 shared paper, 2017
- Sirous Zeinali · 1 shared paper, 2014
- Masoumeh Azizi · 1 shared paper, 2014
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.